PL2170104T3 - Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie - Google Patents

Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie

Info

Publication number
PL2170104T3
PL2170104T3 PL08766831T PL08766831T PL2170104T3 PL 2170104 T3 PL2170104 T3 PL 2170104T3 PL 08766831 T PL08766831 T PL 08766831T PL 08766831 T PL08766831 T PL 08766831T PL 2170104 T3 PL2170104 T3 PL 2170104T3
Authority
PL
Poland
Prior art keywords
signs
patients
nutritional composition
csf
predicting dementia
Prior art date
Application number
PL08766831T
Other languages
English (en)
Other versions
PL2170104T5 (pl
Inventor
Robert Johan Joseph Hageman
Patrick Joseph Gerardus Hendrikus Kamphuis
Ladislaus Maria Broersen
Original Assignee
Nutricia Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39085446&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2170104(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nutricia Nv filed Critical Nutricia Nv
Publication of PL2170104T3 publication Critical patent/PL2170104T3/pl
Publication of PL2170104T5 publication Critical patent/PL2170104T5/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12—Fatty acids or derivatives thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
    • A23P20/00—Coating of foodstuffs; Coatings therefor; Making laminated, multi-layered, stuffed or hollow foodstuffs
    • A23P20/10—Coating with edible coatings, e.g. with oils or fats
    • A23P20/15—Apparatus or processes for coating with liquid or semi-liquid products
    • A23P20/18—Apparatus or processes for coating with liquid or semi-liquid products by spray-coating, fluidised-bed coating or coating by casting
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Confectionery (AREA)
PL08766831.5T 2007-06-27 2008-06-20 Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie PL2170104T5 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
PCT/NL2007/050310 WO2009002148A1 (en) 2007-06-27 2007-06-27 Food composition for prodromal dementia patients
PCT/NL2008/050408 WO2009002164A1 (en) 2007-06-27 2008-06-20 Food composition for prodromal dementia patients
EP08766831.5A EP2170104B2 (en) 2007-06-27 2008-06-20 Food composition for prodromal dementia patients

Publications (2)

Publication Number Publication Date
PL2170104T3 true PL2170104T3 (pl) 2012-02-29
PL2170104T5 PL2170104T5 (pl) 2025-09-08

Family

ID=39085446

Family Applications (2)

Application Number Title Priority Date Filing Date
PL08766831.5T PL2170104T5 (pl) 2007-06-27 2008-06-20 Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie
PL11181091T PL2412250T3 (pl) 2007-06-27 2008-06-20 Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL11181091T PL2412250T3 (pl) 2007-06-27 2008-06-20 Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie

Country Status (20)

Country Link
US (1) US8445458B2 (pl)
EP (2) EP2412250B1 (pl)
JP (1) JP5906014B2 (pl)
CN (1) CN101686723A (pl)
AT (1) ATE524077T1 (pl)
AU (1) AU2008269726B2 (pl)
BR (1) BRPI0813912B1 (pl)
CA (1) CA2704906C (pl)
DK (1) DK2412250T3 (pl)
ES (2) ES2373001T5 (pl)
FI (1) FI2170104T4 (pl)
HU (1) HUE028126T2 (pl)
IL (1) IL202967A (pl)
MX (1) MX2009014217A (pl)
NZ (1) NZ582265A (pl)
PL (2) PL2170104T5 (pl)
PT (2) PT2412250E (pl)
RU (1) RU2487557C2 (pl)
WO (2) WO2009002148A1 (pl)
ZA (1) ZA200909227B (pl)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
WO2009002148A1 (en) 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
PT2170316E (pt) 2007-06-26 2014-01-30 Nutricia Nv Melhoramento de memória em indivíduos com exame de estado mini mental de 24-26
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
CN101951923B (zh) 2007-12-20 2013-10-30 N.V.努特里奇亚 含核苷酸/核苷的液态产品
EP2806568B1 (en) * 2008-02-01 2015-12-30 BlackBerry Limited System and method for uplink timing synchronization in conjunction with discontinuous reception
IT1392312B1 (it) * 2008-12-16 2012-02-24 Pharmarte S R L Formulazione per la somministrazione vaginale a base di acidi grassi polinsaturi omega-3 e di composti del magnesio.
HK1201744A1 (en) * 2011-10-31 2015-09-11 N.V. Nutricia Composition for improving neuropsychological test battery score
WO2013066153A1 (en) 2011-10-31 2013-05-10 N.V. Nutricia Composition for improving neuropsychological test battery score
WO2013066151A1 (en) 2011-10-31 2013-05-10 N.V. Nutricia Improving recognition
WO2013066152A1 (en) * 2011-10-31 2013-05-10 N.V. Nutricia Method for improving executive function
US20150044138A1 (en) * 2012-03-02 2015-02-12 N.V. Nutricia Method for improving functional synaptic connectivity
WO2013129914A1 (en) 2012-03-02 2013-09-06 N.V. Nutricia Method for improving functional synaptic connectivity
WO2013154733A1 (en) * 2012-04-09 2013-10-17 Hill James W Protein restriction for disease prevention and treatment
CN105451730A (zh) * 2013-06-10 2016-03-30 雅培制药有限公司 用于增强认知性能的方法和组合物
WO2015115886A1 (en) * 2014-01-31 2015-08-06 N.V. Nutricia Method for treating, stabilizing or slowing down brain glucose metabolism deficit
WO2015115885A1 (en) 2014-01-31 2015-08-06 N.V. Nutricia Method for reducing white matter lesions, white matter hyperintensities (wmh), leukoaraiosis or periventricular white matter disease in elderly
GB201405033D0 (en) 2014-03-20 2014-05-07 Isis Innovation Combination therapy
WO2015160247A1 (en) * 2014-04-14 2015-10-22 N.V. Nutricia Method for assessing and treating or preventing impaired plasma polar lipid levels
WO2017069613A1 (en) 2015-10-23 2017-04-27 N.V. Nutricia Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients
WO2017155386A1 (en) * 2016-03-08 2017-09-14 N.V. Nutricia Method for treating brain atrophy
WO2017155387A1 (en) 2016-03-08 2017-09-14 N.V. Nutricia Method for supporting memory function and/or cognitive function
WO2017213490A1 (en) 2016-06-10 2017-12-14 N.V. Nutricia Method for controlling neuroinflammation
WO2018038599A1 (en) 2016-08-23 2018-03-01 N.V. Nutricia Product and method for increasing uridine concentration in blood plasma
AU2017336291B2 (en) * 2016-09-29 2023-01-12 Société des Produits Nestlé S.A. Omega 3 fatty acids, no releasing compound and vitamin B12 as neuroprotectant in patients with no dementia
AU2017408873A1 (en) * 2017-04-11 2019-08-29 Societe Des Produits Nestle S.A. Omega-3 fatty acid and vitamin D levels to identify and attenuate cognitive aging in individuals
JP6818331B2 (ja) * 2019-04-24 2021-01-20 株式会社Ｈｂｃフナト 軽度認知障害を治療又は予防するための組成物
CN117956908A (zh) * 2021-09-17 2024-04-30 N·V·努特里奇亚 适合作为营养组合物或补充剂用于患有脑相关障碍、衰退或疾病的动物的固体组合物

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3600197A (en) * 1968-08-27 1971-08-17 Merck & Co Inc Flavor enhancing compositions for foods and beverages
EP0175468A3 (en) 1984-08-10 1987-07-22 Sentrachem Limited Eicosanoids for use in cancer therapy
JP2525624B2 (ja) 1987-09-21 1996-08-21 雪印乳業株式会社 多価不飽和脂肪酸配合育児用粉乳
JPH06237734A (ja) 1991-11-06 1994-08-30 Sanwa Kagaku Kenkyusho Co Ltd 機能後退性疾患用食品組成物
JP3576318B2 (ja) 1996-06-19 2004-10-13 明治乳業株式会社 核酸関連物質含有栄養組成物
JPH10136937A (ja) 1996-11-08 1998-05-26 Takashi Morita 脳細胞機能向上、血管細胞強化、身体各細胞機能向上栄養総合食品
EP0843972B1 (en) * 1996-11-20 2002-07-31 N.V. Nutricia Nutritional composition comprising fats for the treatment of the metabolic syndrome
JP3731983B2 (ja) * 1997-08-27 2006-01-05 明治製菓株式会社 痴呆犬の夜鳴き改善薬
US8518882B2 (en) 1998-07-31 2013-08-27 Massachusetts Institute Of Technology Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
US20070004670A1 (en) 1998-07-31 2007-01-04 Richard Wurtman Compositions containing citicoline, and methods of use thereof
FR2787799B1 (fr) 1998-12-23 2001-03-09 Rhodia Chimie Sa Composition comprenant une ecorce inorganique et un noyau comportant au moins un compose polyhydroxyle
GB9916536D0 (en) * 1999-07-14 1999-09-15 Scarista Limited Nutritional or pharmaceutical compositions
EP1090636A1 (en) 1999-09-13 2001-04-11 Société des Produits Nestlé S.A. High lipid diet
GB9925709D0 (en) 1999-10-30 1999-12-29 Smithkline Beecham Plc Composition
US6835750B1 (en) * 2000-05-01 2004-12-28 Accera, Inc. Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
US7226916B1 (en) 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
PL209031B1 (pl) 2001-04-30 2011-07-29 Trommsdorff Arzneimittel Estry urydyny, ich zastosowanie i sposób wytwarzania, oraz kompozycje farmaceutyczne je zawierające
US6942874B2 (en) 2001-05-25 2005-09-13 Linguagen Corp. Nucleotide compounds that block the bitter taste of oral compositions
EP1285590A1 (en) 2001-08-08 2003-02-26 Société des Produits Nestlé S.A. Lipid blends
NL1019368C2 (nl) * 2001-11-14 2003-05-20 Nutricia Nv Preparaat voor het verbeteren van receptorwerking.
US20030114415A1 (en) 2001-12-14 2003-06-19 Wurtman Richard J. Compositions and methods for treating and preventing memory impairment using citicoline
US20040001817A1 (en) * 2002-05-14 2004-01-01 Giampapa Vincent C. Anti-aging nutritional supplement
NZ546785A (en) 2003-10-24 2009-07-31 Nutricia Nv Immunemodulating oligosaccharides
US7090879B2 (en) * 2004-03-18 2006-08-15 Abbott Laboratories Nutritional formula containing select carotenoid combinations
CA2566612C (en) * 2004-05-13 2015-06-30 Massachusetts Institute Of Technology Uridine effects on dopamine release
WO2006031683A2 (en) * 2004-09-15 2006-03-23 Massachusetts Institute Of Technology Compositions containing uridine, and methods utilizing same
EP1656839A1 (en) 2004-11-11 2006-05-17 N.V. Nutricia Nutrition containing lipid blend
US20060252775A1 (en) 2005-05-03 2006-11-09 Henderson Samuel T Methods for reducing levels of disease associated proteins
ES2624702T5 (es) * 2005-05-23 2020-12-11 Massachusetts Inst Technology Composiciones que contienen PUFA y/o uridina y métodos para su uso
EP2468273A3 (en) 2005-06-20 2012-07-11 Accera, Inc. Method to reduce oxidative damage and improve mitochondrial efficiency
JP5967855B2 (ja) 2005-06-30 2016-08-10 サントリーホールディングス株式会社 日中活動量の低下および／又はうつ症状の改善作用を有する組成物
JP5697293B2 (ja) 2005-06-30 2015-04-08 サントリーホールディングス株式会社 器質的脳障害に起因する高次脳機能の低下に対する改善作用を有する組成物
CN101262863B (zh) * 2005-07-08 2016-08-31 Dsmip资产公司 用于治疗痴呆和前痴呆相关病症的多不饱和脂肪酸
WO2007058523A1 (en) * 2005-11-17 2007-05-24 N.V. Nutricia Composition with docosapentaenoic acid
US20070140992A1 (en) * 2005-12-21 2007-06-21 Lynn Schick Taste masking of essential oils using a hydrocolloid
ATE509624T1 (de) * 2005-12-23 2011-06-15 Nutricia Nv Zusammensetzung enthaltend mehrfach ungesättigte fettsäuren, proteine, mangan und/oder molybden und nukleotide/nukleoside, zur behandlung von demenz
PT2170316E (pt) 2007-06-26 2014-01-30 Nutricia Nv Melhoramento de memória em indivíduos com exame de estado mini mental de 24-26
WO2009002146A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Supporting activities of daily living
WO2009002148A1 (en) 2007-06-27 2008-12-31 N.V. Nutricia Food composition for prodromal dementia patients
WO2009002145A1 (en) 2007-06-26 2008-12-31 N.V. Nutricia Lipid composition for improving function of brain functioning
CN101951923B (zh) * 2007-12-20 2013-10-30 N.V.努特里奇亚 含核苷酸/核苷的液态产品

Also Published As

Publication number Publication date
EP2170104B2 (en) 2024-04-10
EP2170104A1 (en) 2010-04-07
ES2373001T5 (es) 2024-11-13
US8445458B2 (en) 2013-05-21
PL2412250T3 (pl) 2016-01-29
DK2412250T3 (en) 2015-11-16
HUE028126T2 (en) 2016-11-28
WO2009002164A1 (en) 2008-12-31
NZ582265A (en) 2012-07-27
EP2170104B1 (en) 2011-09-14
BRPI0813912A2 (pt) 2015-01-06
CN101686723A (zh) 2010-03-31
RU2487557C2 (ru) 2013-07-20
CA2704906C (en) 2016-08-02
BRPI0813912B1 (pt) 2019-01-02
FI2170104T4 (fi) 2024-06-20
EP2412250A2 (en) 2012-02-01
ATE524077T1 (de) 2011-09-15
JP5906014B2 (ja) 2016-04-20
ES2373001T3 (es) 2012-01-30
AU2008269726B2 (en) 2014-06-19
WO2009002148A1 (en) 2008-12-31
IL202967A (en) 2012-10-31
US20100323982A1 (en) 2010-12-23
EP2412250A3 (en) 2012-02-22
JP2010533647A (ja) 2010-10-28
BRPI0813912A8 (pt) 2018-07-31
ZA200909227B (en) 2010-09-29
CA2704906A1 (en) 2008-12-31
MX2009014217A (es) 2010-03-15
PL2170104T5 (pl) 2025-09-08
AU2008269726A1 (en) 2008-12-31
PT2170104E (pt) 2012-01-03
EP2412250B1 (en) 2015-08-05
ES2551237T3 (es) 2015-11-17
RU2010102526A (ru) 2011-08-10
PT2412250E (pt) 2015-11-13

Similar Documents

Publication Publication Date Title
PL2170104T3 (pl) Kompozycja żywieniowa dla pacjentów z objawami zapowiadającymi otępienie
DK2436275T3 (da) Lipidsammensætning til forbedring af hjernefunktion
WO2007092509A3 (en) Dietary supplement composition for blood lipid health
CO6470839A2 (es) Composiciones farmacéuticas que contienen epa y un agente cardiovascular y métodos de emplearlas
ECSP077401A (es) Medicamentos que contienen compuestos de carbonilo y su uso
NO20080855L (no) Behandling med azetidinon-baserte kolesterol absorpsjonsinhibitorer og omega-3 fettsyrer og et kombinasjonsprodukt derav
BRPI0517462A (pt) métodos e materiais para conferir resistência a pestes e patógenos de plantas
ATE488517T1 (de) 3 -amino- imidazo ä1,2-aüpyridinderivate mit sglt1 und sglt2 hemmender wirkung zur behandlung von diabetes vom typ 1 und typ 2
EP1899856A4 (en) PLAYING AND COMPILING MULTIPLE APPLICATIONS IN AN INTERACTIVE MEDIA ENVIRONMENT
ATE518432T1 (de) Herstellung von lebensmittelprodukten mit verbesserter oraler und mentaler erfrischung
NZ599292A (en) Vitamin d compositions and method of administration to a human being
BRPI1008210A2 (pt) "emulsão óleo-em-água e produto alimentício que compreende uma emulsão óleo-em-água"
SV2003000712A (es) Dispositivos y metodos para aplicacion vertida ref. 497363sv:ssi
BRPI0620229A8 (pt) formulação
UY29236A1 (es) 2-alcoxi-3,4,5-trihidroxi-alquilamidas. su preparación, composiciones que las contienen y su utilización.
DE60101859D1 (de) Pinolensäure gegen Diabetes
AR051932A1 (es) Ciertas plantas con niveles de acidos grasos "no saturados", o saturados reducidos en semillas, y aceite derivado de las semillas
DK1863570T3 (da) Synergistisk varmestabilt oliemedium med eicosapentaensyre (EPA) og decosahexaensyre (DHA)
Brouillard Student and faculty perceptions of the causes and solutions to truancy
Hundal Indian Medical Students' Knowledge and Attitudes about HIV/AIDS
ITBO20060204A1 (it) Dispositivo per l'apertura di buste contenenti prodotti alimentari o simili.
ITMI20051932A1 (it) Etichetta per dischi smeriglio o simili ad elevata resistenza contro l'alterazione degli elementi grafici stampati
ITRM20060514A1 (it) Schermo per la simulazione di stimolazione magnetica transcranica ripetitiva rtms e dispositivo per la somministrazione e la simulazione di rtms provvisto di tale schermo
ITBG20030044A1 (it) Laminato multistrato da impiegarsi per la realizzazione di materassi e /o simili prodotti.
ITRM20050569A1 (it) Dispositivo di visualizzazione elettronica su dislpay del contenuto di salvadanai e simili.